(VIANEWS) – The NASDAQ ended the session with Vertex Pharmaceuticals (VRTX) jumping 4.21% to $283.77 on Thursday while NASDAQ jumped 1.62% to $11,232.19.
Today’s last reported volume for Vertex Pharmaceuticals is 2241750, 32.17% above its average volume of 1696000.
Vertex Pharmaceuticals’s last close was $272.31, 6.98% below its 52-week high of $292.75.
The company’s growth estimates for the current quarter and the next is 13.8% and 1.1%, respectively.
Vertex Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 7.57B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Vertex Pharmaceuticals’s stock is considered to be oversold (<=20).
Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals’s stock is valued at $283.77 at 22:29 EST, below its 52-week high of $292.75 and way above its 52-week low of $176.36.
Vertex Pharmaceuticals’s Moving Average
Vertex Pharmaceuticals’s worth is above its 50-day moving average of $265.47 and way higher than its 200-day moving average of $226.32.
More news about Vertex Pharmaceuticals (VRTX).